Dextromethorphan Hydrobromide; Quinidine Sulfate Patent Expiration
Dextromethorphan Hydrobromide; Quinidine Sulfate is Used for managing symptoms of pseudobulbar affect. It was first introduced by Avanir Pharmaceuticals Inc
Dextromethorphan Hydrobromide; Quinidine Sulfate Patents
Given below is the list of patents protecting Dextromethorphan Hydrobromide; Quinidine Sulfate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Nuedexta | US7659282 | Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders | Aug 13, 2026 | Avanir Pharms |
| Nuedexta | US8227484 | Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders |
Jul 17, 2023
(Expired) | Avanir Pharms |
| Nuedexta | USRE38115 | Dextromethorphan and an oxidase inhibitor for treating intractable conditions |
Jan 26, 2016
(Expired) | Avanir Pharms |
Explore Our Curated Drug Screens
Dextromethorphan Hydrobromide; Quinidine Sulfate Generics
Only one generic application has been filed for Dextromethorphan Hydrobromide; Quinidine Sulfate.
Given below is the list of companies who have filed for Dextromethorphan Hydrobromide; Quinidine Sulfate generic.
1. ACTAVIS ELIZABETH
Actavis Elizabeth Llc has filed for 1 generic for Dextromethorphan Hydrobromide; Quinidine Sulfate. This 20mg;10mg version comes by the name DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE. Given below are the details of the strengths of this generic introduced by Actavis Elizabeth.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG; 10MG | capsule | Prescription | ORAL | AB | Oct 10, 2017 |